UiPath, Inc.
For the period ended Apr 30, 2025. Filed Jun 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2025 · Filed Jun 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
- Organization and Description of Business
Description of Business
UiPath, Inc. ("UiPath," the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. The UiPath Platform™ isdesigned to unify AI agents, robots, and people on a single intelligent system. With open and secure orchestration at its core, the platform allows customers to create, deploy, and manage these resources with scalability, flexibility, and compliance, enabling them to safely and confidently scale agentic automation and transform complex business processes.
- Summary of Significant Accounting Policies
Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2025 Form 10-K. There have been no significant changes to such policies during the three months ended April 30, 2025.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2025, which are included in the 2025 Form 10-K.
The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.
The results of operations for the three months ended April 30, 2025 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2026 or for any other future interim or annual period.
Fiscal Year
Our fiscal year ends on January 31. References to fiscal year 2026, for example, refer to the fiscal year ending January 31, 2026.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development and internal-use software costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, amount of self-insurance liability, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency
The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other (expense) income, net in the condensed consolidated statements of operations. For the three months ended April 30, 2025 and 2024, we recognized foreign currency transaction (losses) gains of $(13.1) million and $2.8 million, respectively.
Concentration of Risks
Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.
We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2025 and January 31, 2025,92% and 86%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.
The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.
With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain an allowance for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2025 and 2024, no single customer accounted for 10% or more of our total revenue. As of April 30, 2025 and January 31, 2025, no single customer accounted for 10% or more of our accounts receivable.
Segment Information
Our chief operating decision maker ("CODM") is our Chief Executive Officer ("CEO"). The CODM reviews financial information at the consolidated level and manages business activities asone operating and reportable segment. Because the assets of our single reportable segment are presented as total assets on our condensed consolidated balance sheets, no other measure of segment assets is regularly provided to the CODM. Net (loss) income, as reported on our condensed consolidated statements of operations, is one of the measures of segment profit or loss used by our CODM to evaluate performance relative to plan, make resource allocation decisions, and monitor profitability trends.
Significant Segment Expenses
Revenue is reduced by significant expenses regularly provided to the CODM, as well as other segment items, to arrive at net loss for the periods presented as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $356,624 | $335,112 |
| Significant segment expenses: | ||
| Adjusted cost of licenses(1) | 1,028 | 1,757 |
| Adjusted cost of subscription services(1)(2)(3)(4) | 33,385 | 31,708 |
| Adjusted cost of professional services and other(2)(3) | 21,366 | 13,434 |
| Adjusted sales and marketing(1)(2)(3)(4) | 133,191 | 142,148 |
| Adjusted research and development(2)(3)(4) | 60,185 | 55,831 |
| Adjusted general and administrative(1)(2)(3)(4)(5) | 37,853 | 39,869 |
| Other segment items(6) | 100,584 | 87,123 |
| Amortization of acquired intangible assets | 1,408 | 2,028 |
| Interest income | (12,648) | (13,830) |
| Provision for income taxes | 2,827 | 3,780 |
| Net loss | $(22,555) | $(28,736) |
| (1) Excludes amortization of acquired intangible assets | ||
| (2) Excludes stock-based-compensation | ||
| (3) Excludes employer payroll tax on employee equity transactions | ||
| (4) Excludes restructuring costs | ||
| (5) Excludes charitable donation of Class A common stock | ||
| (6) Other segment items include stock-based compensation expense; employer payroll tax expense related to employee equity transactions; restructuring costs; charitable donation of Class A common stock; and other (expense) income, net. | ||
Recently Issued Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this ASU on our condensed consolidated financial statements.
In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures. ASU No. 2024-03 requires additional disclosure on specific expense categories included in the expense captions presented on the statements of operations, and may be applied prospectively or retrospectively. ASU No. 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and for interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of this ASU on our condensed consolidated financial statements.
- Revenue Recognition
Disaggregation of Revenue
The following tables summarize revenue by geographical region (dollars in thousands):
| Three Months Ended April 30, | ||||
|---|---|---|---|---|
| 2025 | 2024 | |||
| Amount | Percentage of Revenue | Amount | Percentage of Revenue | |
| Americas (1) | $161,407 | 45% | $153,111 | 46% |
| Europe, Middle East, and Africa | 123,664 | 35% | 104,627 | 31% |
| Asia-Pacific (2) | 71,553 | 20% | 77,374 | 23% |
| Total revenue | $356,624 | 100% | $335,112 | 100% |
(1)Revenue from the U.S. represented 42% and 42% of our total revenues for the three months ended April 30, 2025 and 2024, respectively.
(2)Revenue from Japan represented 10% and 13% of our total revenues for the three months ended April 30, 2025 and 2024, respectively.
Deferred Revenue
During the three months ended April 30, 2025 and 2024, we recognized $210.3 million and $182.3 million of revenue that was included in the deferred revenue balance as of January 31, 2025 and 2024, respectively.
Remaining Performance Obligations
Our remaining performance obligations are comprised of licenses, subscription services, and professional services not yet delivered. As of April 30, 2025, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,231.3 million, which consists of $672.0 million of billed consideration and $559.3 million of unbilled consideration. We expect to recognize 63% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.
Deferred Contract Acquisition Costs
Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $21.3 million and $18.5 million for the three months ended April 30, 2025, and 2024, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.
- Marketable Securities
The following is a summary of our marketable securities (in thousands):
| As of April 30, 2025 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |
| Treasury bills and U.S. government securities | 741,023 | 349 | (105) | 741,267 |
| Corporate bonds | 120,142 | — | (63) | 120,079 |
| Commercial paper | 24,775 | 4 | — | 24,779 |
| Yankee bonds | 4,736 | — | (2) | 4,734 |
| Total marketable securities | $890,676 | $353 | $(170) | $890,859 |
| As of January 31, 2025 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |
| Treasury bills and U.S. government securities | 703,740 | — | (421) | 703,319 |
| Corporate bonds | 93,989 | 36 | — | 94,025 |
| Commercial paper | 42,371 | 20 | — | 42,391 |
| Yankee bonds | 4,707 | — | (7) | 4,700 |
| Total marketable securities | $844,807 | $56 | $(428) | $844,435 |
As of April 30, 2025 and January 31, 2025, $36.5 million and $94.1 million, respectively, of our marketable securities had remaining contractual maturities of one year or more.
As of April 30, 2025 and January 31, 2025, $1.4 million and $2.4 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2025 or January 31, 2025.
Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.
- Fair Value Measurement
The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2025 and January 31, 2025 (in thousands):
| As of April 30, 2025 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Financial assets: | ||||
| Money market funds | $222,386 | $— | $— | $222,386 |
| Total cash equivalents | 222,386 | — | — | 222,386 |
| Treasury bills and U.S. government securities | 741,267 | — | — | 741,267 |
| Corporate bonds | — | 120,079 | — | 120,079 |
| Commercial paper | — | 24,779 | — | 24,779 |
| Yankee bonds | — | 4,734 | — | 4,734 |
| Total marketable securities | 741,267 | 149,592 | — | 890,859 |
| Other investments carried at fair value | — | — | 13,001 | 13,001 |
| Total | $963,653 | $149,592 | $13,001 | $1,126,246 |
| Financial liabilities: | ||||
| Contingent consideration | — | — | 1,835 | 1,835 |
| Total | $— | $— | $1,835 | $1,835 |
| As of January 31, 2025 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Financial assets: | ||||
| Money market funds | $311,942 | $— | $— | $311,942 |
| Total cash equivalents | 311,942 | — | — | 311,942 |
| Treasury bills and U.S. government securities | 703,319 | — | — | 703,319 |
| Corporate bonds | — | 94,025 | — | 94,025 |
| Commercial paper | — | 42,391 | — | 42,391 |
| Yankee bonds | — | 4,700 | — | 4,700 |
| Total marketable securities | 703,319 | 141,116 | — | 844,435 |
| Other investments carried at fair value | — | $— | $11,879 | $11,879 |
| Total | $1,015,261 | $141,116 | $11,879 | $1,168,256 |
Our money market funds and treasury bills and U.S. government securities are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify corporate bonds, commercial paper, and Yankee bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Other investments carried at fair value (which consist of convertible bonds of private company the H Company purchased during fiscal year 2025) and contingent consideration associated with business acquisition are classified as Level 3 because their valuation relies on unobservable inputs.
- Business Acquisition
Peak AI Limited
On March 7, 2025, we acquired all outstanding equity of Peak AI Limited ("Peak"), a UK-based software company that provides pricing and inventory intelligence technology. With this acquisition, we gain an experienced team, established customer relationships in retail and manufacturing sectors, and technology that is optimized for industry-specific use cases.
The total purchase consideration for the acquisition of Peak was $40.1 million, consisting of initial cash consideration of $30.3 million and deferred and contingent consideration with an aggregate acquisition-date fair value of $9.8 million.
The Peak acquisition is accounted for as a business combination. We expect to finalize purchase accounting as soon as practicable, but no later than one year from the acquisition date. The following table summarizes the provisional allocation of purchase price to the assets acquired and liabilities assumed as of the acquisition date (in thousands):
| March 7, 2025 | |
|---|---|
| Intangible assets | $16,181 |
| Other net liabilities | (4,055) |
| Goodwill | 27,964 |
| Total | $40,090 |
The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the acquisition date:
| Fair Value (in thousands) | Estimated Useful Life (in years) | |
|---|---|---|
| Customer relationships | $9,228 | 3.0 |
| Developed technology | 6,447 | 5.0 |
| Trade names and trademarks | 506 | 3.0 |
| Total | $16,181 |
The acquisition of Peak generated goodwill of$28.0 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes.
- Intangible Assets and Goodwill
Intangible Assets, Net
Acquired intangible assets, net consisted of the following as of April 30, 2025 (dollars in thousands):
| Intangible Assets, Gross | Accumulated Amortization | Intangible Assets, Net | Weighted-Average Remaining Useful Life (years) | |
|---|---|---|---|---|
| Developed technology | $36,826 | $(23,820) | $13,006 | 3.5 |
| Customer relationships | 18,256 | (8,355) | 9,901 | 2.8 |
| Trade names and trademarks | 811 | (290) | 521 | 2.9 |
| Other intangibles | 1,231 | (605) | 626 | 6.3 |
| Total | $57,124 | $(33,070) | $24,054 |
Acquired intangible assets, net consisted of the following as of January 31, 2025 (dollars in thousands):
| Intangible Assets, Gross | Accumulated Amortization | Intangible Assets, Net | Weighted-Average Remaining Useful Life (years) | |
|---|---|---|---|---|
| Developed technology | $28,130 | $(21,416) | $6,714 | 2.2 |
| Customer relationships | 8,183 | (7,648) | 535 | 0.5 |
| Trade names and trademarks | 271 | (271) | — | 0.0 |
| Other intangibles | 1,231 | (575) | 656 | 6.4 |
| Total | $37,815 | $(29,910) | $7,905 |
We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets was $1.4 million and $2.0 million for the three months ended April 30, 2025 and 2024, respectively.
Expected future amortization expense related to intangible assets was as follows as of April 30, 2025 (in thousands):
| Amount | |
|---|---|
| Remainder of year ending January 31, 2026 | $6,814 |
| Year ending January 31, | |
| 2027 | 7,373 |
| 2028 | 6,028 |
| 2029 | 2,040 |
| 2030 | 1,428 |
| Thereafter | 371 |
| Total | $24,054 |
Goodwill
Changes in the carrying amount of goodwill during the three months ended April 30, 2025 were as follows (in thousands):
| Carrying Amount | |
|---|---|
| Balance as of January 31, 2025 | $87,304 |
| Acquisition of Peak | 27,964 |
| Effect of foreign currency translation | 6,103 |
| Balance as of April 30, 2025 | $121,371 |
- Operating Leases
Our operating leases consist of real estate and vehicles and have remaining lease terms ofone year to 13 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees.
Lease costs are presented below (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating lease cost | $3,377 | $3,476 |
| Short-term lease cost | 660 | 1,123 |
| Variable lease cost | 938 | 523 |
| Total | $4,975 | $5,122 |
The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:
| As of | ||
|---|---|---|
| April 30,2025 | January 31,2025 | |
| Weighted-average remaining lease term (years) | 9.9 | 10.1 |
| Weighted-average discount rate | 7.4% | 7.2% |
Future undiscounted lease payments for our operating lease liabilities as of April 30, 2025 were as follows (in thousands):
| Amount | |
|---|---|
| Remainder of year ending January 31, 2026 | $7,007 |
| Year ending January 31, | |
| 2027 | 14,990 |
| 2028 | 13,530 |
| 2029 | 9,981 |
| 2030 | 8,913 |
| Thereafter | 57,191 |
| Total operating lease payments | 111,612 |
| Less: imputed interest | (32,660) |
| Total operating lease liabilities | $78,952 |
As of April 30, 2025, we had non-cancellable commitments in the amount of $0.3 million related to operating leases of vehicles that have not yet commenced.
Current operating lease liabilities of $5.5 million and $3.6 million were included inaccrued expenses and other current liabilities on our condensed consolidated balance sheets as of April 30, 2025 and January 31, 2025, respectively.
Supplemental cash flow information related to leases for the three months ended April 30, 2025 and 2024 was as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash paid for amounts included in the measurement of operating lease liabilities | $4,470 | $3,653 |
| Operating lease ROU assets obtained in exchange for new operating lease liabilities | 755 | 7,044 |
- Condensed Consolidated Balance Sheet Components
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
| As of | ||
|---|---|---|
| April 30,2025 | January 31,2025 | |
| Prepaid expenses and service credits | $66,651 | $65,334 |
| Other current assets | 32,616 | 20,942 |
| Prepaid expenses and other current assets | $99,267 | $86,276 |
Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
| As of | ||
|---|---|---|
| April 30,2025 | January 31,2025 | |
| Computers and equipment | $25,107 | $23,677 |
| Leasehold improvements | 32,376 | 31,402 |
| Furniture and fixtures | 7,790 | 7,124 |
| Construction in progress | 18,761 | 9,562 |
| Other | 681 | 635 |
| Property and equipment, gross | 84,715 | 72,400 |
| Less: accumulated depreciation | (42,751) | (39,660) |
| Property and equipment, net | $41,964 | $32,740 |
Depreciation expense for the three months ended April 30, 2025 and 2024 was $1.3 million and $2.3 million, respectively.
Other Assets, Non-Current
As of April 30, 2025 and January 31, 2025, other assets, non-current included $26.6 million and $24.4 million, respectively, related to equity investments in private companies without readily determinable fair values. As a measurement alternative, these investments are reported at cost and are assessed periodically to determine whether their carrying value must be adjusted for observable changes in price or indicators of impairment.
As of April 30, 2025 and January 31, 2025, other assets, non-current also included $13.0 million and $11.9 million, respectively, related to private-company convertible bonds, which are carried at fair value. Refer to Note 5, Fair Value Measurement for further information.
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
| As of | ||
|---|---|---|
| April 30,2025 | January 31,2025 | |
| Accrued expenses | $37,467 | $19,810 |
| Withholding tax from employee equity transactions | 3,160 | 4,699 |
| Employee stock purchase plan withholdings | 7,759 | 3,335 |
| Payroll taxes and other benefits payable | 9,658 | 8,258 |
| Income taxes payable | 3,616 | 1,632 |
| Value-added taxes payable | 2,530 | 3,640 |
| Operating lease liabilities, current | 5,519 | 3,587 |
| Deferred consideration for business acquisition | 8,000 | — |
| Contingent consideration for business acquisition | 1,835 | — |
| Rebates payable to partners | 16,751 | 13,314 |
| Cloud infrastructure liabilities | 7,411 | 6,685 |
| Other | 19,428 | 18,963 |
| Accrued expenses and other current liabilities | $123,134 | $83,923 |
- Commitments and Contingencies
Letters of Credit
We had a total of $2.7 million and$2.6 million in letters of credit outstanding in favor of certain landlords for office space as of April 30, 2025 and January 31, 2025, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2027.
Indemnification
In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties.
These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of April 30, 2025 and January 31, 2025, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements is remote.
Workforce Restructuring
On July 8, 2024, our board of directors approved restructuring actions (the "Fiscal Year 2025 Workforce Restructuring") to reshape the organization by streamlining our structure, particularly in operational and corporate functions, to better prioritize our go-to-market investments and focus our research and development invest ments on artificial intelligence ("AI") and driving innovation across our platform. The Fiscal Year 2025 Workforce Restructuring is substantially completed, with any remaining actions expected to be completed by July 31, 2025.
The following table presents the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related costs as of April 30, 2025 (in thousands):
| Employee Termination Benefits | |
|---|---|
| Accrued restructuring costs as of January 31, 2025 | $9,778 |
| Restructuring costs incurred during the three months ended April 30, 2025 | 3,011 |
| Amount paid during the three months ended April 30, 2025 | (9,782) |
| Accrued restructuring costs as of April 30, 2025 | $3,007 |
The following table presents restructuring charges, consisting primarily of employee termination benefits, incurred during the three months ended April 30, 2025 by financial statement line item (in thousands):
| Employee Termination Benefits | |
|---|---|
| Cost of subscription services revenue | $458 |
| Sales and marketing | 1,981 |
| Research and development | (331) |
| General and administrative | 903 |
| Total | $3,011 |
Defined Contribution Plans
We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans were $5.5 million and $6.2 million for the three months ended April 30, 2025 and 2024, respectively.
Litigation
From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 450, Contingencies, we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
UiPath and certain of its officers and directors are currently parties to the following litigation matters:
On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-Chief Executive Officer ("Co-CEO") Daniel Dines, and Chief Financial Officer ("CFO") Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the "2023 Securities Action"). The initial complaint asserted claims under Sections 10(b) and 20(a) of the Exchange Act, and alleged that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January 26, 2024, the lead plaintiff in the 2023 Securities Action filed an amended complaint, and on March 26, 2024, filed a further amended complaint, which alleges Securities Act claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. On April 23, 2024, the defendants moved to dismiss the second amended complaint. On November 4, 2024, the Court issued its opinion and order on the motion to dismiss, wherein it dismissed all claims under the Securities Act, but allowed the case to proceed with respect to two statements relating to competition that the plaintiffs allege violated the Exchange Act. On February 28, 2025, plaintiff filed a motion for Class Certification and Appointment of Class Representative and Class Counsel, and on April 29, 2025, defendants filed their opposition to the motion. On May 29, 2025, the plaintiff sought leave of the court to amend the second amended complaint.
On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the 2023 Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware (captioned In re UiPath, Inc. Stockholder Derivative Litigation) and in the Southern District of New York (captioned Ristea v. Botteri, et al.). On November 22, 2024, the In re UiPath, Inc. Stockholder Derivative Litigation case was voluntarily dismissed without prejudice. On January 8, 2025, the Polilingua Limited v. Daniel Dines, et al. case was voluntarily dismissed without prejudice. On February 5, 2025, the Ristea v. Botteri, et al. case was voluntarily dismissed without prejudice.
On June 20, 2024, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, CEO Daniel Dines, former CEO Robert Enslin, and CFO Ashim Gupta. The case was captioned Steiner v. UiPath, et al. The complaint asserts claims under Sections 10(b) and 20(a) of the Exchange Act on behalf of a putative class of persons who purchased or acquired UiPath common stock between December 1, 2023 and May 29, 2024, and alleges that defendants made material misstatements and omissions, including regarding the Company's AI-powered Business Automation Platform and the Company's strategy for, the success of, and customer demand for the platform. The complaint seeks unspecified monetary damages, costs and attorneys' fees, and other unspecified relief as the Court deems appropriate. On August 6, 2024, a second putative class action was filed in the United States District Court for the Southern District of New York against UiPath, CEO Daniel Dines, former CEO Robert Enslin, and CFO Ashim Gupta. The case was captioned Brunozzi v. UiPath, et al. The allegations in the Brunozzi complaint were identical to those made in Steiner v. UiPath et al. except that the Brunozzi complaint defines the putative class to include purchasers of UiPath call options and sellers of put options. On September 5, 2024, the Court consolidated the Steiner and Brunozzi cases and appointed Brunozzi as the lead plaintiff. The consolidated action is captioned In re UiPath, Inc. Securities Litigation (the "2024 Securities Action"). On November 22, 2024, the lead plaintiff filed an amended complaint against UiPath, former CEO Robert Enslin, and CFO Ashim Gupta. CEO Daniel Dines is no longer a named defendant in the 2024 Securities Action. The allegations in the amended complaints are substantively similar to the allegations set forth in the complaints previously filed in Steiner and Brunozzi, and the amended complaint seeks unspecified monetary damages, costs and attorneys' fees, and other unspecified relief as the Court deems appropriate. On April 21, 2025, the defendants motion to dismiss the amended complaint was fully submitted to the Court.
On July 8, 2024 and April 17, 2025, purported shareholder derivative lawsuits were filed in the United States District Court for the Southern District of New York against UiPath, as nominal defendant, CEO Daniel Dines, former CEO Robert Enslin, CFO Ashim Gupta, and UiPath's board of directors. The cases are captioned Gera v. UiPath, et al. and Murie v. Botteri, et al., respectively. The lawsuits allege that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements made during the time period at issue in the 2024 Securities Action, and by allegedly causing UiPath to repurchase shares at allegedly inflated prices. The plaintiffs seek unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys' fees and certain changes to UiPath's corporate governance and internal controls. These matters have been stayed pending further action in the 2024 Securities Action.
We havenot recorded any accrual related to the aforementioned litigation matters as of April 30, 2025, as we believe a loss in these matters is neither probable nor estimable at this time.
Warranty
We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made.
Other Matters
Our indirect tax positions are subject to audit in multiple jurisdictions globally, with a key focus on our largest operational territories, including the U.S., Romania, India, and the U.K.
Our Romanian subsidiary was subjected to audits by the Agenția Națională de Administrare Fiscală ("ANAF") for value-added tax and corporate income tax for the periods January 2020 through January 2022 and January 2018 through January 2022, respectively, which were completed during the first quarter of fiscal year 2025. With regard to the value-added tax audit, an assessment of $14.3 million has been issued. While we paid this assessment during fiscal year 2025, we disagree with the assessment and are in the process of appealing through litigation. The amount of the payment is included in other assets, non-current on our condensed consolidated balance sheet as of April 30, 2025, and we havenot recorded any estimated liability related to this litigation as of April 30, 2025, as we believe it is not probable that a material loss has been incurred.
Additionally, our Romanian subsidiary is currently subject to audit for value-added tax for the periods of February 2022 through April 2024. While the audit is ongoing, and no official assessment has been issued, we estimate a possible loss of approximately $13.0 million. We havenot recorded any estimated liability related to this audit as of April 30, 2025, as we believe it is not probable that a material loss will be incurred.
Our Indian subsidiary is currently subject to audits for goods and services tax for the period April 2018 through March 2024. A preliminary inquiry for certain transactions with a Goods and Services Tax ("GST") amount of $52.1 million has been raised. We are preparing our responses to the tax authority's requests. We havenot recorded any estimated tax liability related to this audit as of April 30, 2025, as we believe it is not probable that a material loss will be incurred.
For additional information regarding tax audits, refer to Note 13, Income Taxes.
Non-Cancelable Purchase Obligations
In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and purchase of credits toward products and services from strategic alliance partners.
As of April 30, 2025, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):
| Amount | |
|---|---|
| Remainder of year ending January 31, 2026 | $65,299 |
| Year ending January 31, | |
| 2027 | 67,880 |
| 2028 | 26,647 |
| 2029 | 2,368 |
| 2030 | 4 |
| Thereafter | — |
| Total | $162,198 |
- Stockholders’ Equity
Stock Repurchase Program
On September 1, 2023, our board of directors authorized a stock repurchase program which authorized the repurchase from time to time of up to $500.0 million of our outstanding shares of Class A common stock. This authorization was scheduled to expire on March 1, 2025. On August 30, 2024, our board of directors authorized the repurchase of an additional $500.0 million of our Class A common stock. The current authorization may be suspended or discontinued at any time and does not have a specified expiration date. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
We repurchased 21.9 million shares of our Class A common stock at an average price of $10.40 per share during the three months ended April 30, 2025 and 0.9 million shares of our Class A common stock at an average price of$23.46 per share during the three months ended April 30, 2024 (inclusive of brokerage commission). For the three months ended April 30, 2025 and 2024, we accrued $1.9 million andnone, respectively, of related excise tax pursuant to the Inflation Reduction Act of 2022, which is included in the cost of treasury stock on our condensed consolidated balance sheets.
Charitable Donations of Class A Common Stock
We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during each of the three-month periods ended April 30, 2025 and 2024 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $4.2 million and $6.6 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2025 and 2024, respectively.
Conversion of Class B Common Stock to Class A Common Stock
On March 13, 2025,5.0 million shares of Class B common stock beneficially owned by CEO Daniel Dines were converted into Class A common stock in connection with a previously disclosed Rule 10b5-1 trading plan. All remaining outstanding shares of Class B common stock continue to be beneficially owned by Mr. Dines.
Accumulated Other Comprehensive Income
For the three months ended April 30, 2025 and 2024, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands):
| Foreign Currency Translation Adjustments | Unrealized Gain (Loss) on Marketable Securities | Accumulated Other Comprehensive Income | |
|---|---|---|---|
| Balance as of January 31, 2025 | $(4,518) | $(372) | $(4,890) |
| Other comprehensive income, net of tax | 33,857 | 556 | 34,413 |
| Balance as of April 30, 2025 | $29,339 | $184 | $29,523 |
| Foreign Currency Translation Adjustments | Unrealized Loss on Marketable Securities | Accumulated Other Comprehensive Income | |
|---|---|---|---|
| Balance as of January 31, 2024 | $8,925 | $(100) | $8,825 |
| Other comprehensive loss, net of tax | (3,574) | (511) | (4,085) |
| Balance as of April 30, 2024 | $5,351 | $(611) | $4,740 |
- Equity Incentive Plans and Stock-Based Compensation
2021 Stock Plan
In April 2021, prior to and in connection with our initial public offering ("IPO"), we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance stock units
("PSUs"), and other forms of awards. As of April 30, 2025, we have reserved 229.8 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period often years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1)5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase.
2021 Employee Stock Purchase Plan
In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of April 30, 2025, the ESPP authorizes the issuance of 32.7 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period often years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1)1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2)15.5 million shares, except that before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a)85% of the fair market value of our Class A common stock as of the commencement of the offering period, and (b)85% of the fair market value of our Class A common stock on the corresponding purchase date.
Stock Options
Stock option activity during the three months ended April 30, 2025 was as follows:
| Stock Options(in thousands) | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Life (years) | Aggregate Intrinsic Value(in thousands) | |
|---|---|---|---|---|
| Outstanding as of January 31, 2025 | 7,935 | $0.60 | 7.5 | $108,138 |
| Granted | 2,371 | $0.10 | ||
| Exercised | (851) | $0.36 | ||
| Forfeited | (99) | $0.10 | ||
| Outstanding as of April 30, 2025 | 9,356 | $0.50 | 7.9 | $107,089 |
| Vested and exercisable as of April 30, 2025 | 3,172 | $1.26 | 6.0 | $33,868 |
The weighted-average grant date fair value of stock options granted during the three months ended April 30, 2025 was $9.93 per share. The intrinsic value of stock options exercised during the three months ended April 30, 2025 was $8.9 million.
Unrecognized compensation expense associated with unvested stock options granted and outstanding as of April 30, 2025 was approximately $85.9 million, which is expected to be recognized over a weighted-average remaining period of 2.0 years.
Restricted Stock Units
RSU activity during the three months ended April 30, 2025 was as follows:
| RSUs(in thousands) | Weighted-Average Grant Date Fair Value Per Share | |
|---|---|---|
| Unvested as of January 31, 2025 | 22,449 | $17.81 |
| Granted | 10,836 | $10.19 |
| Vested | (3,127) | $19.80 |
| Forfeited | (1,600) | $18.49 |
| Unvested as of April 30, 2025 | 28,558 | $14.66 |
The fair value of RSUs released during the three months ended April 30, 2025 was $32.2 million.
As of April 30, 2025, total unrecognized compensation expense related to unvested RSUs was approximately $392.9 million, which is expected to be recognized over a weighted-average remaining period of 2.2 years.
Performance Stock Units
During the three months ended April 30, 2025, we granted 0.7 million PSUs subject to performance conditions related to the achievement of certain Company targets for fiscal year 2026, with a potential payout ranging from 0% to 150% of the base number of PSUs awarded (with some PSUs having a maximum payout of 150% and others having a maximum payout of 125%). To the extent that they are earned, these PSUs will vest over three years.
As of April 30, 2025, total unrecognized compensation expense related to unvested PSUs expected to vest was approximately $4.0 million, which is expected to be recognized over a weighted-average remaining period of 2.9 years.
Employee Stock Purchase Plan Awards
As of April 30, 2025, total unrecognized compensation expense related to the ESPP was approximately $0.7 million, which is expected to be recognized over a weighted-average remaining period of 0.1 years.
Stock-Based Compensation Associated with Business Acquisition
At the closing of the acquisition of Re:infer LTD on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of April 30, 2025, total unrecognized compensation expense related to these shares was $0.6 million, which is expected to be recognized over a weighted-average remaining period of 0.2 years.
Stock-Based Compensation Expense
Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cost of subscription services revenue | $3,874 | $4,276 |
| Cost of professional services and other revenue | 2,728 | 2,470 |
| Sales and marketing | 23,586 | 36,216 |
| Research and development | 34,595 | 29,142 |
| General and administrative | 11,578 | 16,623 |
| Total | $76,361 | $88,727 |
- Income Taxes
Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate may change due to several factors, including the relative amount of income we earn in various jurisdictions and certain book-tax differences.
We had a provision for income taxes of $2.8 million, reflecting an effective tax rate of(14.3)%, and $3.8 million, reflecting an effective tax rate of (15.1)%, for the three months ended April 30, 2025 and 2024, respectively.
For the three months ended April 30, 2025 and 2024, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax expenses due to a full valuation allowance on U.S. and Romania deferred tax assets ("DTAs") and due to tax rate differences between the U.S. and foreign countries.
The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. As of April 30, 2025, based on the available positive and negative evidence, we believe it is more likely than not that the DTAs associated with the U.S. and Romania will not be realized and we continue to maintain a full valuation allowance against such DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, each of the respective valuation allowances.
As of April 30, 2025, we had gross unrecognized tax benefits totaling $1.6 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.9 million, excluding interest and penalties, which are accounted for as a component of our income tax provision.
Our tax positions are subject to income tax audits in multiple tax jurisdictions globally. Our estimates of the potential outcome of any uncertain tax position is subject to management's assessment of the relevant risks, facts, and circumstances existing at that time. We believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. However, our future results may include adjustments to estimates in the period the audits are settled, which may impact our effective tax rate.
Our Indian subsidiary is currently appealing the corporate income tax assessment of$2.1 million for the audit period of April 2019 through March 2021. It also has an open corporate income tax audit for the period from April 2022 through March 2024. Our Romanian subsidiary is currently appealing the corporate income tax audit decision for the period from January 2018 through January 2022. In addition, we have engaged intwo bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway, the authorities are in the process of determining the cost sharing allocations between the respective countries, and the ultimate outcomes remain uncertain.
On December 20, 2021, the Organization for Economic Co-operation and Development ("OECD") published the Pillar Two Model Rules defining the global minimum tax for multinational enterprises with an annual revenue above€750.0 million. The OECD has since issued administrative guidance providing transition and safe harbor rules around the implementation of the Pillar Two global minimum tax. We have assessed the impact of the Pillar Two rules and included the impact when calculating estimated annual effective tax rate for the current year.
- Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):
| Three Months Ended April 30, | ||||
|---|---|---|---|---|
| 2025 | 2024 | |||
| Class A | Class B | Class A | Class B | |
| Numerator: | ||||
| Net loss | $(19,277) | $(3,278) | $(24,579) | $(4,157) |
| Denominator: | ||||
| Weighted-average shares used in computing net loss per share, basic and diluted | 468,751 | 79,700 | 487,472 | 82,453 |
| Net loss per share, basic and diluted | $(0.04) | $(0.04) | $(0.05) | $(0.05) |
Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):
| Three Months Ended April 30, | ||||
|---|---|---|---|---|
| 2025 | 2024 | |||
| Class A | Class B | Class A | Class B | |
| Unvested RSUs | 25,881 | — | 32,230 | — |
| Outstanding stock options | 8,830 | — | 10,946 | — |
| Shares issuable under ESPP | 1,043 | — | 690 | — |
| Unvested PSUs | 205 | — | — | — |
| Returnable shares issued in connection with business acquisition | 136 | — | 274 | — |
| Shares subject to repurchase from RSAs and early exercised stock options | — | — | 28 | — |
| Total | 36,095 | — | 44,168 | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.